Holiday season is not over!!!
Celebrating our 20th anniversary, we offer one more month of free accommodation – 3 nights in 4*hotel. We are looking forward to welcoming you in early spring!
Japanese researchers from Kyoto University aim to conduct clinical research on a possible therapy for Parkinson's disease involving transplantation of induced pluripotent stem cells.
A total of 3,000 patients will be involved in the trial to test whether life can be prolonged by administering stem cells from the patient's own bone marrow.
Korean scientists from Seoul University suggested a new way to restore heart function of patients suffering from chronic myocardial infarction.All news
Cell Therapy Center EmCell was founded in 1994. In all these years, we treated thousands of patients from different countries and performed more than 8,000 transplantations of fetal stem cells. The treatment methods developed and used in the center helped to save and prolong our patients' lives, restore different organs and tissues and achieve positive results in treating diseases and conditions that were considered incurable.
EmCell professionals perform fetal stem cell treatment (in vivo), work out indications and contraindications for the treatment of severe acquired and genetic diseases caused by or resulting in cell count reduction. Moreover, our center performs treatment for a wide range of conditions, such as aging, climax, infertility, functional disorders of the internal organs and chronic fatigue syndrome.
All the methods of fetal stem cell treatment used at our center are its property and protected by the patents of Ukraine, Russia, the USA and other countries. At present, a number of patents on fetal stem cell application for different diseases and conditions treatment are pending in the patent offices of many countries.
BBC documentary called EmCell the "Last Hope Clinic" because we treated and followed-up the most complicated clinical cases from all over the world.
During the years of intensive work, EmCell team won international acclaim in the field of research and clinical application of fetal stem cells. Our achievements were awarded a number of certificates of the international medical congresses and conferences. But the best award for EmCell is successful treatment and recovery of our patients and their words of gratitude.
EmCell history is remarkable for invention of fetal stem cell isolation methods and pioneering in their practical application.
|1987||treatment of cytostatic myelodepression and aplastic anemia (filing of patent application)|
|1991||clinical trials and invention of acquired immune deficiency syndrome (AIDS) and HIV-infection treatment method; filing of patent application in the USA (priority dates back to 1993).|
|1992||successful application of fetal stem cells (in vivo) for treatment of type 1 and 2 diabetes mellitus and filing of patent application|
|1993-1994||foundation of the Cell Therapy Clinic of the National Medical University (Kiev, Ukraine). Clinical trials of cell transplants for treatment of different diseases and conditions. First Ukrainian patents were granted. First efforts in development of multiple sclerosis treatment methods.|
|1995||application of fetal stem cells (in vivo) for treatment of amyotrophic lateral sclerosis. First efforts to apply different types of cell suspensions for treatment of muscular dystrophies, in particular Duchenne Muscular Dystrophy|
|1998-2001||Greek, USA, Russian Federation and Ukrainian patents granted.|
|2002||Most Innovative Work Award granted by the Scientific Committee of the Annual Meeting of the Society of Medical Innovations and Technology (SMIT) held in Oslo, Norway. The first Dutch patent granted.|
|2003||the second Dutch patent granted.|
|2004||Ukrainian and Russian Federation patents granted. Development and patenting of methods of intestine diseases treatment (Crohn’s disease, non-specific ulcerative colitis, etc.). Working out of ethical norms on the work with human fetal cells approved by the Ministry of Health of Ukraine.|
|2005-2007||extension of active clinical and scientific activities, participation in the numerous conferences and congresses, direct participation in the work of international societies and associations, such as Cellular Therapy Society, Cell Transplant Society, Multinational Association of Supportive Care in Cancer, Society for Minimally Invasive Therapy, EASD.|
|2008||development of methods of fetal cell suspensions application in surgical practice, in particular for treatment of erosive-ulcerative lesions of stomach and duodenum complicated by bleeding. Elaboration of patient surveillance that was declared the best at the 1-st Central European Congress on Surgery (Prague, Czech Republic).|
|2011||Cell Therapy Center EmCell is the first stem cell center in Ukraine to receive a state license for fetal cell bank activities, the only specialized license in Ukraine permitting manipulations with stem cells. Licensing requirements for quality and safety of cell transplants produced in EmCell's laboratories as well as for personnel qualifications and equipment are very strict, hence, as of early 2012, only EmCell and one more Ukrainian clinic were granted this license.|
EmCell professionals use modern methods of fetal stem cell isolation and storage. They make fetal cell suspensions, test them and use for clinical and scientific purposes. Creation of cell suspensions and their transplantation at the same facility is a perfect combination as it guarantees the high quality of the cell transplants and allows achieving the best effects.
Biotechnological stages of work with fetal cell suspensions include:
Cell Therapy Center EmCell owns modern cell suspension bank equipped with the high-technology equipment: modern Dewar flasks and large cryogenic banks (tanks) containing tens of thousands of fetal cell suspensions.
Patenting has always been regarded as one of EmCell priorities. We were the first in the world to describe post-transplantation period after fetal stem cell treatment of such diseases as AIDS, HIV-infection, type 1 and 2 diabetes mellitus, aplastic anemia, psoriasis, rheumatoid arthritis, degenerative diseases of nervous system, inflammatory and cancer bowel diseases, etc. In 1993, International Patent Application Examination Board in the Hague awarded them level "A", or absolutely pioneer works.
In our patents we mentioned the possibility of treatment of the large number of diseases and conditions caused by or resulting in cell count reduction. Most of all, we take pride in our US and Dutch patents.
We were the first in the world to offer fetal stem cell-based medicinal preparations and mentioned this in our US, Dutch, Russian and Ukrainian patents. We believe that sales of fetal stem cell-based medicinal preparations in specialized pharmacies for domiciliary or hospital treatment will become possible in this century.
This will create the grounds for the development of the new ideology of practical medicine when medical professional will issue prescription for cell composite consisting of HLA-free stem cells. It is they that will help to cope with illness- or age-related cell deficiency.
Cell Therapy Center EmCell welcomes cooperation for the development of this idea.
We work in the field of the modern branch of science called cell therapy. And we gave our definition of this branch of science. Cell therapy is science about stem cells and their clinical use.
It was in the 1990’s that we realized that this was the science of the method. If disease or condition is caused by or results in cell count reduction, cell therapy can be applied.
Almost all severe acquired and genetic diseases cause destruction of actively functioning cells. Stem cells capable of proliferation (multiplication), differentiation (specialization) and morphogenesis (tissue formation) are effective for tissue and organ function and cell count restoration. Stem cells of fetal origin are the most effective in achieving of the above-mentioned effects as they have the highest proliferative potential.
Since 1991, 7 MMS theses were written by post-graduate students and staff of the Therapy Chair of the National Medical University of Ukraine for whom Prof. A.I. Smikodub was a scientific advisor.
The scope of our scientific interests was wide: it included clinical trials and development of treatment methods for type 1 and 2 diabetes mellitus, AIDS, HIV-infection, leukosis, aplastic anemia, primary and secondary thrombocytopenia, cytostatic myelodepression, cancer diseases, degenerative diseases of central nervous system, multiple sclerosis, amyotrophic lateral sclerosis, muscular dystrophies, such conditions as climax, infertility, aging, as well as functional disturbances of internal organs, chronic fatigue syndrome, application of fetal stem cells in surgical practice, etc.
We regularly attend international and national scientific events where we present our posters, reports and lectures. So far, our professionals took part in a number of international and national conferences and congresses.
EmCell professionals are authors of more than 300 scientific works published in the national as well as international magazines and congress proceedings.
Our center owns the trademark EmCell registered in the USA, Russia and Ukraine.
Many positive articles were published about Cell Therapy Center EmCell, and 4 documentaries were made about our facility, including BBC.
We are available at email@example.com or you can reach us by the telephone +38 067 236 27 61